About a month ago, I received an invitation to attend a “Patient Day” reception hosted by Dr. Emil Kakkis, CEO of Ultragenyx. Ultragenyx is the biotech company that is currently in phase II of a clinical trial for a potential treatment to slow the progression of HIBM.  Dr. Kakkis was throwing a party to celebrate … Continue reading The Jennifer Room